Tissue specific expression of 11BHSD and its effects on plasma corticosterone during the stress response by Perez, Jonathan H. et al.
 
 
 
 
 
Perez, J. H., Swanson, R. E., Lau, H. J., Cheah, J., Bishop, V. R., Snell, K. R.S., Reid, 
A. M.A., Meddle, S. L., Wingfield, J. C. and Krause, J. S. (2020) Tissue specific 
expression of 11BHSD and its effects on plasma corticosterone during the stress 
response. Journal of Experimental Biology, 223, jeb.209346. (doi: 10.1242/jeb.209346)  
 
There may be differences between this version and the published version. You are 
advised to consult the publisher’s version if you wish to cite from it. 
 
 
 
http://eprints.gla.ac.uk/204312/ 
      
 
 
 
 
 
 
Deposited on: 28 November 2019 
 
 
 
Enlighten – Research publications by members of the University of Glasgow 
http://eprints.gla.ac.uk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tissue specific expression of 11BHSD and its effects on plasma corticosterone during the 1 
stress response.  2 
Jonathan H. Pérez1,2,3, Ryan E. Swanson1, Hannah J. Lau1, Jeffrey Cheah1, Valerie R. 3 
Bishop3, Katherine R.S. Snell4, Angus M.A. Reid3,5, Simone L. Meddle3, John C. Wingfield1 4 
& Jesse S. Krause1 5 
 6 
1Department of Neurobiology, Physiology and Behavior, University of California Davis, 7 
One Shields Avenue, Davis, CA 95616, USA. 8 
2The Institute of Biodiversity, Animal Health & Comparative Medicine, University of 9 
Glasgow, Glasgow, G12 8QQ, Scotland, UK. 10 
3The Roslin Institute, The Royal (Dick) School of Veterinary Studies, University of 11 
Edinburgh, Easter Bush, Midlothian, EH25 9RG, Scotland, UK. 12 
4Center for Macroecology, Evolution and Climate; Natural History Museum of Denmark; 13 
University of Copenhagen; Universitetsparken 15; DK-2100 Copenhagen, Denmark. 14 
5MRC HGU, Institute of Genetics and Molecular Medicine, University of Edinburgh, 15 
Western General Hospital, EH4 2XU, Scotland, UK. 16 
 17 
 18 
Running Title: Enzymatic regulation of corticosterone 19 
 20 
This manuscript has 26 pages, 2 table, and 3 figures 21 
 22 
 23 
 24 
 25 
Corresponding author: Jonathan H. Pérez 26 
Jonathan.Perez@glasgow.ac.uk 27 
v1jpere4@exseed.ed.ac.uk 28 
 29 
Key words: glucocorticoid, corticosterone, hypothalamic-pituitary-adrenal (HPA) axis, 30 
11β-HSD, negative feedback, songbird, stress 31 
 
 
Summary Statement 32 
Peripheral enzymes are primarily responsible for enzymatic modulation of the glucocorticoid 33 
stress response in songbirds. 34 
 35 
Abstract 36 
 37 
The hypothalamic-pituitary-adrenal (HPA) axis is under complex regulatory control at multiple 38 
levels. Enzymatic regulation plays an important role in both circulating levels and target tissue 39 
exposure. Three key enzyme pathways are responsible for the immediate control of 40 
glucocorticoids. De novo synthesis of glucocorticoid from cholesterol involves a multistep 41 
enzymatic cascade. This cascade terminates with 11β-hydroxylase, responsible for the final 42 
conversion of 11 deoxy- precursors into active glucocorticoids. Additionally, 11β-hydroxysteroid 43 
dehydrogenase type 1 (11β-HSD1) controls regeneration of glucocorticoids from inactive 44 
metabolites, providing a secondary source of active glucocorticoids. Localized inactivation of 45 
glucocorticoids is under the control of Type 2 11β-HSD (11β-HSD2). The function of these 46 
enzymes is largely unexplored in wild species, particularly songbirds. Here we aim to explore the 47 
contribution of both clearance and generation of glucocorticoids to regulation of the hormonal 48 
stress response via use of pharmacological antagonists. Additionally, we mapped 11β-HSD gene 49 
expression. We found 11β-HSD1 primarily in liver, kidney, and adrenal glands though it was 50 
detectable across all tissue types. 11β-HSD2 was predominately expressed in the adrenal glands 51 
and kidney with moderate gonadal and liver expression. Inhibition of glucocorticoid generation 52 
by metyrapone was found to decrease levels peripherally, while both peripheral and central 53 
DETC administration resulted in elevated concentrations of corticosterone. These data suggest 54 
that during the stress response, peripheral antagonism of the 11β-HSD system has a greater 55 
impact on circulating glucocorticoid levels than central control. Further studies show aim to 56 
elucidate the respective roles of the 11β-HSD and 11β-hydroxylase enzymes. 57 
  58 
 
 
Introduction 59 
 60 
Glucocorticoids are critical for the physiological responses to environmental, both 61 
external and internal, perturbations. In response to acute stressors such as food shortage, 62 
inclement weather or predators, the organism responds by increasing the synthesis of 63 
glucocorticoids from the adrenal glands, giving rise to the classic “stress response”. In the short 64 
term, elevation of glucocorticoids is adaptive promoting changes in physiology and behavior to 65 
promote survival (e.g. Sapolsky et al., 2000; Romero, 2002; Krause et al., 2017). As prolonged 66 
or chronic elevation of glucocorticoids can result in a number of pathological conditions, the 67 
homeostatic regulation of glucocorticoid levels is essential for maximizing fitness. 68 
Regulation of glucocorticoid synthesis and secretion in response to stressors begins with 69 
integration of internal and external cues by the brain. Ultimately, cells in the paraventricular 70 
nucleus (PVN) of the hypothalamus are stimulated causing the release of corticotrophin-71 
releasing factor (CRF) and arginine vasopressin or arginine vasotocin depending on species (e.g. 72 
Joëls et al., 2008). CRF triggers the release of adrenocorticotropic hormone (ACTH) from the 73 
corticotroph cells in the anterior pituitary gland into the systemic circulation. ACTH then acts to 74 
stimulate increased synthesis of glucocorticoids in the adrenal glands. Glucocorticoids not only 75 
signal to target cells, but also provide negative feedback to the hypothalamo-pituitary-adrenal 76 
(HPA) axis regulating further activation of the HPA axis and ultimately returning plasma 77 
hormone levels to baseline. These actions occur through two classes of receptors: the high 78 
affinity mineralocorticoid (MR) and low affinity glucocorticoid (GR) receptors. GR receptor 79 
tends to be bound at high circulating levels of glucocorticoids such as those encountered during a 80 
stress response so GR is considered to be the primary mediator of stress effects and negative 81 
feedback (Reul et al., 1987). Glucocorticoid signaling generates negative feedback by binding to 82 
CRF-neurons in the PVN as well as blocking hippocampal signaling to the CRF neurons, thus 83 
reducing CRF release and inhibiting ACTH release through binding at corticotrophs in the 84 
anterior pituitary gland (de Kloet, 2014). Recent work has suggested a short negative feedback 85 
loop within the adrenal gland itself, with locally produced glucocorticoids serving to suppress 86 
further glucocorticoid synthesis as levels rise (Walker et al., 2015). Thus, negative feedback 87 
regulation of the stress response can broadly be categorized as either central or peripheral 88 
depending upon the site of glucocorticoid signaling involved. Given the importance of 89 
 
 
glucocorticoid receptors in mediating negative feedback control, the majority of research to date 90 
has focused on variation in distribution and concentration of MR and GR within the HPA axis 91 
(Breuner and Orchinik, 2001; Canoine et al., 2007; Harris et al., 2013; de Kloet, 2014; Krause et 92 
al., 2015; Cornelius et al., 2018). To date other mechanisms of stress axis modulation have 93 
received comparatively little attention. 94 
Of particular interest is enzymatic control of glucocorticoid synthesis/regeneration and 95 
localized inactivation. Adrenal generation of active glucocorticoids from cholesterol ends with 96 
the conversion of deoxy- forms (deoxycorticosterone or 11-deoxycortisol) to active 97 
glucocorticoid by the 11β hydroxylase enzyme. The liver also serves as a secondary source of 98 
glucocorticoids through the regeneration of inactive 11 keto-glucocorticoids to glucocorticoids 99 
by the enzyme 11β hydroxysteroid dehydrogenase type 1 (11β-HSD1). Indeed in humans 100 
regeneration of inactive 11 keto-glucocorticoids has been found to account for up to 40 % of 101 
glucocorticoid synthesis (Basu et al., 2004). 11β-HSD1 may also serve to mediate local tissue 102 
level exposure as it has been reported in an array of mammalian tissue types including the brain, 103 
liver, adipose tissue, fat, gonads, vasculature, multiple brain regions, uterus, and muscle (Diaz et 104 
al., 1998; Holmes and Seckl, 2006; Wyrwoll et al., 2011; reviewed in Chapman et al., 2013). 105 
Reports of 11β-HSD1 in avian species are limited with a single study reporting it as undetectable 106 
in the brain of zebra finches, Taeniopygia guttata, (Rensel et al., 2018). 107 
Whereas 11β-HSD1 and 11β hydroxylase act to synthesize and regenerate inactivated 108 
glucocorticoids respectively, 11β hydroxysteroid dehydrogenase type 2 (11β-HSD2) serves as a 109 
key regulator of local exposure to glucocorticoids at the tissue level by inactivating 110 
glucocorticoids to inert metabolites. This is best demonstrated by its well-documented action in 111 
the kidneys where inactivation of glucocorticoids by 11β-HSD2 allows aldosterone, instead of 112 
glucocorticoids, to bind to the non-selective MR receptors. Similar to 11β-HSD1 in birds, 11β-113 
HSD2 has been reported to have a relatively limited neural distribution in mammals and is most 114 
closely associated with protection of developing tissue from excess glucocorticoid signaling and 115 
modulation of neural aldosterone signaling in the adult brain (Wyrwoll et al., 2011). In birds 116 
11β-HSD2 has been described in the chicken (Gallus gallus; Klusoňová et al., 2008) and zebra 117 
finch (Katz et al., 2010; Rensel et al., 2018) in brain, liver, kidney, colon and gonads. The 118 
expression of 11β-HSD enzymes in the brain in particular suggests the potential for altering 119 
negative feedback control of the hormonal stress response. Similarly, peripheral 11β-HSD is 120 
 
 
expected to impact rates of clearance and regeneration of glucocorticoids. Together, these dual 121 
effects may provide a critical mechanism for maintenance of both plasticity and variation 122 
(seasonal and inter-individual) in the functional characteristics of the HPA axis. This is 123 
supported by studies in 11β-HSD1 knockout mice that have demonstrated increased 124 
glucocorticoid secretion in response to restraint stress (Harris et al., 2001).  125 
To date, the role of regulatory enzymes, both in the periphery and brain, in controlling 126 
glucocorticoid levels remains poorly understood in free living animals, particularly birds. Here 127 
we seek to understand the relative contribution of both peripheral and central inactivation (via 128 
11β-HSD2) and activation (via 11β-HSD1 regeneration and 11β-hydroxylase synthesis) of 129 
glucocorticoids in modulating the hormonal stress response. In order to address these major 130 
knowledge gaps, we have taken a multi-step approach utilizing the Gambel's white-crowned 131 
sparrows (Zonotrichia leucophrys gambelii) - a seasonally breeding songbird species with well-132 
characterized stress physiology. First, we quantified mRNA expression of 11β-HSDs across both 133 
central and peripheral tissues in both sexes.  To test the importance of both central and peripheral 134 
enzyme activity we conducted both peripheral and central ICV administration of 135 
pharmacological antagonists targeting both glucocorticoid (hereafter corticosterone, the major 136 
glucocorticoid in birds) generation and clearance. To test the contribution of corticosterone 137 
synthesis in modulating circulating plasma levels we utilized the well-characterized blocker of 138 
corticosterone synthesis metyrapone (MET), shown to block both synthesis by 11β hydroxylase 139 
and 11β-HSD1 regeneration of corticosterone. Simultaneously we utilized a previously identified 140 
selective inhibitor of 11β-HSD2 (Schweizer et al., 2003), sodium diethyldithiocarbamate 141 
trihydrate (DETC; inhibits 11β-HSD2) to block clearance of corticosterone. 142 
 143 
 144 
Materials and Methods 145 
Animals 146 
 147 
Gambel’s White-crowned Sparrows were captured on their wintering grounds near Davis, 148 
California USA (N 38° 33’, W 121°44’) between 2016 and 2017 using a combination of seed 149 
baited potter traps and Japanese mist nets. In December 2016, photosensitive field caught birds 150 
(n= 9 per sex) were euthanized by overdose of isoflurane and following confirmation of death 151 
 
 
brain, pituitary gland, gonad, kidney, liver, fat, gastrocnemius muscle, pectoralis muscle, heart, 152 
and adrenal glands were collected for subsequent RT-PCR analysis. Collected tissues were 153 
immediately fresh frozen on dry ice and stored at - 80°C then shipped to the Roslin Institute on 154 
dry ice, and then stored at - 70°C. Time to euthanasia from capture was 146 + 5 sec and a 155 
baseline blood sample (ca 70 µL) was taken from all animals within 87 + 7 sec of capture to 156 
determine baseline levels of corticosterone. Blood was collected by puncture of the alar vein 157 
with a 26 gauge needle and surface blood collected by heparinized microcapillary tube (41B501; 158 
Kimble Chase, Vineland, NJ USA). 159 
Twenty-eight males and twenty-two females were sampled in the field for Experiment 1 160 
(Peripheral 11β-HSD2 Regulation) from February to March of 2017. In early April 2017 an 161 
additional 26 pre-breeding males were captured and transferred to captivity in aviary facilities at 162 
the University of California, Davis for use in Experiment 2 (Central Regulation). Sex was 163 
determined by PCR followed by gel electrophoresis per (Griffiths et al., 1998) for free living 164 
birds and by necropsy for captive birds. All procedures were approved by UC Davis Institutional 165 
Animal Care and Use Committee (IACUC), protocol # 19758 and followed UK ARRIVE 166 
(ASPA) guidelines. In all experiments birds were randomly assigned to treatment. 167 
 168 
Determining 11β-HSD mRNA Expression 169 
 170 
RNA was extracted from tissues using Zymo DIRECT-zol RNA miniprep kits (Zymo 171 
Research, Irvine CA. USA). Following RNA extraction, total concentration of RNA was 172 
determined via nanodrop. RNA input was equalized tissue-wise for reverse transcription to 173 
cDNA using a High Capacity cDNA Reverse Transcription Kit (Cat no. 4368814; Life 174 
Technologies, Carlsbad, CA USA) prior to quantification. Quantitative polymerase chain 175 
reaction (qPCR) using Brilliant III Ultra-Fast Sybr Green (Agilent Technologies, 176 
http://www.genomic.agilent.com, Santa Clara, CA USA) in Thermofast 96 well detection plates 177 
(AB1100, ThermoFisher, UK) with optical caps (4323032, ThermoFisher, UK) was used to 178 
measure 11β-HSD1 and 11β-HSD2 gene expression. Reactions were performed and samples 179 
counted on a Stratagene MX 3000 Machine and relative measurements calculated using MxPro 180 
software by extrapolation to a standard sample series of defined concentration (standard curve), 181 
as previously described (Reid and Dunn, 2018). Manual examination of reaction quality involved 182 
 
 
examination of dissociation curves for a single peak, check of standard curve correlation 183 
(>0.995) and confirmation of good reaction efficiency (90-110%). Following quality control, 184 
sample size for male gastrocnemius muscle was reduced to 8, and both gonad and pituitary gland 185 
to 6 samples for final analysis. All qPCR data were normalized to the geometric mean value of 186 
two reference genes; 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Zeta 187 
(YWHAZ) and NADH:ubiquinone oxidoreductase subunit A1 (NDUFA1). Primers were 188 
designed based on NCBI (https://www.ncbi.nlm.nih.gov) database entries for available passerine 189 
species: White-throated sparrow (Zonotrichia albicollis) and zebra finch (Taeniopygia guttata) 190 
Two potential sequences were examined for 11β-HSD1 based on a search of NCBI databases and 191 
were denoted 11β-HSD1-762 (XM_005495762.2) and 11β-HSD1-865 (XM_005492865.1). 192 
Based on sequencing and homology data, candidate 11β-HSD1-865 (hereafter referred to as 11β-193 
HSD1) was determined to correctly represent 11β-HSD1 and used for subsequent tissue analysis. 194 
Single sets of primers were designed for 11βHSD2 (XM_014269709.1), YWHAZ 195 
(NM_001031343.1) and NDUFA1 (NM_001302115.1). All primers were validated via standard 196 
PCR of Z. leucophrys cDNA and amplicons sequenced to confirm identity. See Table 1 for 197 
details of primers used. 198 
 199 
Antagonists 200 
 201 
2-Methyl-1,2-di-3-pyridyl-1-propanone - 96% (MET, M2696; Sigma-Aldrich, USA) and 202 
sodium diethyldithiocarbamate trihydrate (DETC, D3506; Sigma-Aldrich, USA) were freshly 203 
prepared in Ringer's Lactated saline (0.9%) to provide an injection volume of 100-200 µL at 204 
desired dosages: MET high 30 mg kg-1, MET low 15 mg kg-1, DETC high 400 mg kg-1, and 205 
DETC low 200 mg kg-1. DETC has been shown to be a selective inhibitor of 11β-HSD2 with an 206 
IC50 of 6.3 ± 3.8 µM and no detectable activity with respect to both reduction and oxidation 207 
reactions catalyzed by 11β-HSD1 (Schweizer et al., 2003). 208 
 209 
Experiment 1: Effects of peripheral injection of DETC and MET on the corticosterone stress 210 
response in free-living white-crowned sparrows 211 
 212 
 
 
Immediately following capture (within 3 min) a baseline blood sample (ca. 70 µL) was 213 
obtained as described above. Birds were weighed by Pesola spring scale to the nearest 0.1 g to 214 
determine appropriate drug dosage. Birds were randomly assigned to one of 5 treatment groups 215 
receiving either: high dose MET (30 mg kg-1; n = 11), low MET (15 mg kg-1; n =12), high dose 216 
DETC (400 mg kg-1; n =13), low dose DETC (200 mg kg-1; n=9), or control (100 µL of Lactated 217 
Ringers solution; 13) via IP injection. Birds were held under a standardized capture restraint 218 
protocol for 60 min with additional blood samples collected at 10, 30 and 60 mins in an opaque 219 
cloth bag (Astheimer et al., 1992). Each bird was banded with a unique US Fish and Wildlife 220 
Service band prior to release. 221 
 222 
Experiment 2: Effects of central administration of DETC and MET on corticosterone stress 223 
response in captive white-crowned sparrows 224 
 225 
Birds were initially housed in two large flight aviaries (3×2.5×2m) on a 11L:13D 226 
photoperiod for acclimation. A total of 24 birds were utilized in the experiment as described 227 
below. A 3:1 mixture of Mazuri Small Bird Maintenance Diet (#56A6; Mazuri, Richmond, IN 228 
USA) and mixed wild bird seed along with water and grit were provided ad libitum. After 30 229 
days birds were transferred to individual cages (35×25×40 cm) and housed in groups of 3-4 in 230 
sound chambers on a fixed photoperiod of 10L:14D for the remaining duration of the 231 
experiment. 232 
Birds were cannulated as previously described (Bentley et al., 2006).   Birds were food 233 
deprived two hours prior to surgery, anesthetized with 2-4% isoflurane with supplemental 234 
oxygen (1 L min-1) and placed into a stereotaxic apparatus specially designed for songbirds 235 
(MyNeuroLab.com). The intersection of the mid-sagittal and transverse sinuses was located on 236 
the skull and served as a reference point. The 11 mm 26 gauge guide cannula (C315G; Plastics 237 
One, Roanoke, VA USA) was moved 2.3 mm anterior from the reference point, lowered 6mm 238 
below the surface of the skull, bonded in place with dental cement (NC9655090; Stoelting Wood 239 
Dale, IL USA) and allowed adequate curing time before the animal was removed from the 240 
stereotaxic frame. A 33 gauge dummy cannula (C315DC; Plastics One, Roanoke, Virginia) was 241 
inserted into the guide cannula to prevent the development of obstruction. Patency of the cannula 242 
was determined by administration of human angiotensin II (A9525-1mg; Sigma-Aldrich, USA) 243 
 
 
which rapidly promotes thirst and drinking behavior within 2 min of infusion (Wada et al., 1975; 244 
Richardson and Boswell, 1993). Only birds that drank within 2 min following the administration 245 
of 1µg of Angiotensin II in 2 µL of sterile LRS were included in experimental treatments. 246 
Birds were divided into three groups (n = 8 per group/round), which initially received one 247 
of the following treatments: control (0.9% sterile saline), MET (20 µg), or DETC (200 µg) 248 
administered in a 2 µL bolus infusion over 2 min by infusion pump (PHD 2000; Harvard 249 
Apparatus, Holliston, MA USA). Central administration was carried out using a 10 µL Hamilton 250 
syringe attached to a clear piece of polyethylene tubing marked to show 1 µL volumes. The 251 
injection cannula (C315I ; Plastics One, Roanoke, VA USA) protruded 0.5 mm past the end of 252 
the guide cannula allowing central administration into the third ventricle. Birds were assigned to 253 
initial treatments such that each chamber received a mix of treatments. Birds were subsequently 254 
rotated through each treatment condition so all birds experienced each treatment over the 3 week 255 
experimental period. Upon opening of each sound chamber a baseline blood sample 256 
(approximately 50 µL) was collected from the alar vein within 3 min or less (as previously 257 
described), prior to administration of the appropriate intracerebroventricular (ICV) infusion. 258 
Additional 50 µL blood samples were collected at 10, 30 and 60 mins post disturbance. Two 259 
birds per chamber were infused and sampled each day, such that all birds were sampled in a two 260 
day period each week. Sampling order was reversed each week.  261 
 262 
Blood sample processing 263 
 264 
All blood samples were stored on ice until processing. Plasma was separated from red blood cells 265 
by centrifuging at 10,000 rpm for 5 min. The plasma was then aspirated via a Hamilton syringe 266 
and placed into microcentrifuge tubes and stored at -30° C until corticosterone quantification. 267 
 268 
Corticosterone Radioimmunoassay 269 
 270 
Corticosterone levels were measured by a radioimmunoassay as previously described by 271 
Wingfield et al. (1992). Briefly, 15 µL of plasma from baseline samples and 10 µL of the post 272 
capture time points were assayed. Recovery efficiency was estimated by adding 2000 CPM of 273 
tritiated corticosterone (Perkin Elmer NET399250UC, Waltham, MA USA) to each sample prior 274 
 
 
to extraction. Corticosterone was extracted from the samples by incubating with 4 mL of re-275 
distilled dichloromethane with regular vortexing (D154-4; Fisher Chemical, Pittsburgh, PA 276 
USA). The aqueous phase was then extracted into a clean 10 mL test tube and the samples were 277 
dried in a water bath at 35°C under nitrogen gas, prior to being reconstituted using 550 µL of 278 
phosphate buffered saline gelatin (PBSG). The reconstituted samples were separated into 200 µL 279 
duplicate aliquots for quantification and 100 µL retained for determination of recovery efficacy. 280 
Recovery samples were combined with 2 mL of scintillation fluid (Ultima Gold: 6013329; 281 
Perkin Elmer, Waltham, MA USA) and counted to determine the percent recovery for each 282 
sample. 100 µL of tritiated corticosterone and 100 µL antiserum (07–120016, lot 3R3-PB-20E; 283 
MP Biomedical, Santa Ana, CA USA) were added to each duplicate assay tube and incubated 284 
overnight at 4°C. 500 µL of dextran-coated charcoal was added to each duplicate and after 285 
exactly 12 min, samples were centrifuged at 3000 rpm for 10 min at 4°C. The supernatant was 286 
decanted into scintillation vials and combined with 4 mL of scintillation fluid (Perkin Elmer 287 
Ultima Gold: 6013329, Waltham, MA USA). Samples were placed on a Beckman 6500 liquid 288 
scintillation counter and each vial was counted for 5 min or within 2% accuracy. The 289 
corticosterone values were determined from a standard curve and adjusted using the 290 
corresponding recovery percentage. Mean recoveries were 82.7% and intra-assay (calculated 291 
using C.V. between duplicates) and inter-assay variations were 7.25% and 10.87%, respectively. 292 
The detection limit of the assays was 8.85 ± 0.49 pg per tube (~0.7 ng mL-1 per tube). 293 
 294 
Statistical Analyses  295 
 296 
All statistical analyses were performed in R  (R Core Development Team, 2018) using 297 
packages: pracma (Borchers, 2017), ggplot2 (Wickham, 2009), lme4 (Bates et al., 2014), 298 
lmerTest (Kunznetsova et al., 2014), emmeans (Lenth, 2019) and tidyr (Wickham and Henry, 299 
2018). Normalized gene expression data was analyzed by ANOVA and post-hoc testing 300 
performed using Tukey’s Honestly Significant Difference tests. Sex differences between tissues 301 
were not tested based on the absence of main or interaction effects of sex. For the peripheral 302 
injection study the data low and high doses of DETC and MET were compared via linear mixed 303 
effects model with a dose by handling time interaction individually to determine any dose effect. 304 
As no significant main effect (DETC: F1,66 = 1.77, p = 0.188; MET: F1,35 = 0.18, p = 0.674) of 305 
 
 
dose nor any interaction with restraint time (DETC: F1,64 = 0.001, p = 0.975; MET: F1,60 = 0.09, p 306 
= 0.764) was found, the dosages were combined for each drug for all subsequent analyses. 307 
Subsequently a fully parameterized linear mixed effects model of Treatment, Restraint Time, and 308 
Sex and all interactions was tested and no effect of sex nor interaction was detected. This model 309 
returned as rank deficient thus a second model with the main effect of Treatment, Restraint Time 310 
and Sex as well at the interaction of Treatment and restraint time was tested and again sex was 311 
found to be non-significant (F2,51= 1.83, p = 0.172) and thus sex was excluded from further 312 
analyses. A final base model of the interaction of Restraint Time and Treatment (MET, DETC, 313 
and saline) with both band number (unique identifier) and corticosterone assay number included 314 
as random intercepts to account for repeated sampling and intra-assay variation respectively, was 315 
used. The dosage of the drug had no effect for MET (F1,22 = 0.12, P = 0.85) nor for DETC (F1,18 = 316 
2.58, P = 0.12) in field samples, thus in both cases dosages were combined to increase statistical 317 
power. Following detection of significant effect in the linear mixed effects model, post hoc tests 318 
were performed using estimated marginal means with Tukey’s Honestly Significant Difference 319 
and Kenward-Roger estimation of degrees of freedom in the emmeans package. Integrated 320 
corticosterone was determined by calculation of area under the curve using the function trapz in 321 
the pracma package in R. Integrated corticosterone was analyzed by linear mixed effects model 322 
with fixed effect of Drug and random effects matched to experimental design (see Table 2 for 323 
final models). All data are reported as the mean ± standard error of the mean (s.e.m).  324 
 325 
Results  326 
 327 
11β -HSD Gene Expression 328 
 329 
 11β-HSD1 and 11β-HSD2 were detected across tissues (Figs 1,2). 11β-HSD1 expression 330 
differed significantly between tissues (Fig. 1; F10, 169 = 54.94, p < 0.001) and tissue level 331 
expression patterns varied by sex (F10, 169 = 2.60, p = 0.006). Expression of 11βHSD1 was 332 
highest in liver for both sexes (Fig. 1), though sexes differed significantly from each other (F1,169 333 
= 0.339, p < 0.001). 11β-HSD1 expression was detected in the hippocampus, hypothalamus and 334 
anterior pituitary gland, but was close to the lower limit of detection in all three tissues (Fig. 1). 335 
11β-HSD2 expression also differed significantly between tissues (Fig. 2; F10,170 = 63.24, p < 336 
 
 
0.001), but no effect of sex (F1,170 = 1.33, p = 0.251) nor sex by tissue interaction was detected 337 
(F10,170 = 1.41, p = 0.181). As with 11β-HSD1 expression, 11β-HSD2 was low but present in the 338 
hippocampus, hypothalamus and anterior pituitary (Fig. 2).  339 
 340 
Experiment 1: Effects of peripheral antagonist injections on corticosterone concentrations 341 
during the stress response in free living white-crowned sparrows 342 
 343 
 The final model consisted of restraint time, treatment and their interaction with the 344 
random effect of bird. Corticosterone was found to increase independent of treatment with 345 
duration of restraint stress (Fig. 3A; F1,200 = 103.98, p < 0.001). Treatment also significantly 346 
altered plasma corticosterone levels (F2,200 = 7.22, p < 0.001). DETC treatment resulted in 347 
significant elevation of corticosterone at 10 min compared to MET (DETC-MET: t171 = 5.47, p < 348 
0.001), at 30 min post capture compared to both Saline and MET groups (DETC-Saline: t169 = 349 
4.36, p < 0.001; DETC-MET: t174 = 9.23, p < 0.001), and at 60 minutes post capture compared to 350 
MET (t174 = 3.04, p = 0.007). Peripheral injection of MET resulted in decreased corticosterone 351 
compared to Saline at 30 minutes post capture (t171 = -3.36, p = 0.003). 352 
Total integrated corticosterone secreted over the hour restraint period, as calculated by 353 
area under the curve, was affected by treatment (Fig. 3B; F2,45 = 25.9, p < 0.001). DETC 354 
significantly increased corticosterone compared to Saline (t45 = 3.15, p = 0.008) and MET (t45 = 355 
7.17, p< 0.001). MET treatment reduced total corticosterone secreted compared to Saline 356 
controls (t45 = -2.88, p = 0.017). 357 
 358 
Experiment 2: Effects of central ICV administration of antagonists on corticosterone stress 359 
response in captive white-crowned sparrows 360 
 361 
Corticosterone concentrations increased over the 60 min restraint period across 362 
treatments (Fig. 3C; F1, 192 = 45.8, p <0.001). The increase of corticosterone concentrations over 363 
time was found to be dependent upon drug type infused (F2, 192 = 4.14, p = 0.02).  There were no 364 
differences between treatments detected at the 0 and 10 min time points. DETC treated birds had 365 
significantly higher corticosterone at 30 (Fig.3B; DETC-Saline: t193 = 4.81, p < 0.001; DETC-366 
MET: t188 = 3.38, p =0.04) and 60 min post restraint (DETC-Saline: t193 = 3.37, p = 0.02; DETC-367 
 
 
MET: t188 = 3.53, p =0.026). Corticosterone concentration in response to MET infusion did not 368 
differ from Saline controls at any time point (p > 0.05). 369 
Total corticosterone secreted showed a trend towards being affected by drug infused (Fig. 370 
3D; F2,31 = 2.68, p = 0.084). However, post-hoc testing detected no difference between treatment 371 
groups in total corticosterone secreted, though DETC infusion (t36 =1.79, p = 0.19) trends 372 
towards increasing corticosterone as compared to saline when inspected graphically.  373 
 374 
Discussion: 375 
 376 
11β-HSD gene expression 377 
 378 
Detection of 11β-HSD expression across tissues supports a functional role in regulation 379 
of tissue specific and circulating corticosterone levels in birds. Consistent with previous reports 380 
in birds we found 11β-HSD1 expression to be highest in the liver (Rensel et al., 2018) and 11β-381 
HSD2 to be highest in the kidney and detectable levels in the gonads, liver and brain (Klusoňová 382 
et al., 2008; Katz et al., 2010; Rensel et al., 2018). This expression across body tissues supports 383 
the established major role of 11β-HSD1 in the hepatic generation of active glucocorticoids from 384 
circulating precursors (Rensel et al., 2018) and 11β-HSD2 protection of renal aldosterone 385 
signaling via protection of MR from corticosterone binding.  386 
For the first time we report expression of both 11β-HSD1 and 11β-HSD2 in the adrenal 387 
glands of a bird. While, the presence of 11β-HSD1 in the adrenal gland is expected, given its key 388 
role in corticosterone biosynthesis, the presence of 11β-HSD2 is surprising as it inactivates 389 
corticosterone. We found 11β-HSD2 levels here to be 2-3 times higher than in the kidney (the 390 
second-highest site of expression). Protection of the adrenal glands from toxic levels of 391 
corticosterone and modulation of local autocrine or paracrine feedback loops by 11β-HSD2, may 392 
explain these findings. This is supported by data from rats and humans showing that adrenal 11β-393 
HSD2 expression is concentrated primarily in the zona fasciculata, where glucocorticoid 394 
synthesis occurs, with lower expression into the zona reticularis and medulla (Roland and 395 
Funder, 1996; Mazzocchi et al., 1998) and none in the capsule and zona glomerulosa (site of 396 
mineralocorticoid synthesis). Mazzocchi and colleagues (1998) also found 11β-HSD2 activity in 397 
human adrenal preparations to be indirectly responsive to exogenous ACTH. This modulation of 398 
 
 
adrenal 11β-HSD2 and its distribution suggests the possibility of dynamic modulation of 399 
glucocorticoid production within the adrenal gland itself over the course of the stress response. 400 
Such modulation of glucocorticoid secretion by adrenal 11β-HSD2 remains to be tested in avian 401 
systems. 402 
Hypothalamic expression of both 11β-HSD enzymes were low compared to expression in 403 
peripheral tissues. These results are consistent with previous studies in zebra finches (Katz et al., 404 
2010; Rensel et al., 2018). Zebra finch 11β-HSD2 expression was found to be widespread across 405 
the brain, and has been suggested to be driven by the widespread neural expression of MR in this 406 
species as compared to mammals and other birds  (Katz et al., 2010). The present study lacks the 407 
necessary data to test this hypothesis and whether it is a unique feature of zebra finches.  408 
 409 
Peripheral and central MET administration 410 
Our findings suggest that MET's efficacy may be context and species dependent as inly 411 
peripheral administration had minimal detectable effect. Previous studies have demonstrated the 412 
efficacy of MET in inhibiting corticosterone synthesis in rodents, with a dose of 40 mg/kg 413 
generating robust suppression in rats (Herman et al., 1992). Previous studies in birds, utilizing 414 
implants to deliver MET in a time released manner, had no prolonged effect on corticosterone 415 
levels in house sparrows (Gray et al., 1990; Aharon-Rotman et al., 2017). Though this may be 416 
taken to suggest that MET simply lacks efficacy in avian species, the lowest levels of circulating 417 
corticosterone was found to occur two days after implant placement with levels rising over the 418 
course of the study (Aharon-Rotman et al., 2017). This suggests that MET implants are able to 419 
alter basal corticosterone levels, but that these alterations are unable to overcome homeostatic 420 
control in the long run. These results combined with the findings of the present study support a 421 
limited efficacy of MET in disrupting generation of corticosterone in birds. The single short term 422 
bolus injection approach used in this study may have enabled us to better detect METs effects. 423 
However, our data also suggest that MET has a very limited ability to alter corticosterone levels 424 
in birds. Further interpretation of MET’s specific actions is limited. Further studies are necessary 425 
to disentangle the role of 11β hydroxylase action from that of 11β-HSD1. 426 
 427 
Inhibition of 11β-HSD2 by peripheral and central DETC administration 428 
 429 
 
 
Peripheral administration of DETC effectively blocked 11β-HSD2 action, as evidenced 430 
by the increase in circulating corticosterone (Fig.3A&B) as predicted by previous cell based 431 
assays utilizing DETC (Atanasov et al., 2003; Schweizer et al., 2003). This suggests that 432 
peripheral 11β-HSD2, in addition to providing localized protection at the level of the target 433 
tissue, also serves to modulate circulating levels of corticosterone. Of particular interest in this 434 
respect is the high level of 11β-HSD2 expressed in the adrenal glands, previously unreported in 435 
songbirds. Contrary to our a priori predictions, central DETC administration also resulted in 436 
elevated circulating corticosterone levels over the restraint period (Fig.3C). Blocking of 437 
hypothalamic 11β-HSD2 was expected to lead to a local elevation of corticosterone, thereby 438 
increasing negative feedback and ultimately lowering the total amount of corticosterone secreted 439 
or at least increasing the speed at which corticosterone returned to baseline. Instead we see a 440 
trend towards increased total corticosterone secreted in response to DETC infusion into the 3V 441 
(Fig. 3D). Examination of the present data in light of the broader literature, including the ability 442 
of  DETC to cross the blood brain barrier (Frank et al., 1995), supports two broad hypotheses. 443 
First, the escape of centrally injected DETC into the periphery to act upon the major sites of 444 
corticosterone inactivation, the kidney and liver. While physically possible, the small volume of 445 
DETC administered via ICV (representing a comparatively tiny absolute DETC dosage in 446 
comparison to the peripheral injections), makes escape of centrally administered DETC to the 447 
periphery a highly unlikely explanation. Alternatively, DETC within the brain may inhibit as yet 448 
uncharacterized sites of neural stress axis regulation, that in the absence of normal 11β-HSD2 449 
protective action trigger positive feedback supporting the further release of corticosterone. Future 450 
studies utilizing labelled corticosterone to determine tissue level processing in response to 451 
antagonist treatment will be necessary to elucidate the role 11β-HSD2 in regulation of the stress 452 
axis. Furthermore, conditional knockout models may provide a robust alternative, but are 453 
presently not widely available in avian systems. 454 
 455 
Role of 11β-HSD2 enzymes in regulation of the stress response 456 
  457 
 Our findings support a critical role for 11β-HSD2 in the regulation of circulating levels of 458 
corticosterone. The high peripheral gene expression and clear reduction in systemic clearance 459 
observed in response to peripheral blocking of 11β-HSD2 suggest that peripheral 11β-HSD2 460 
 
 
action contributes more to regulation of the hormonal stress response than central 11β-HSD2 461 
activity, if this indeed exists. It is critical to recall that the presence of 11β-HSD2 in multiple 462 
peripheral tissues may complicate interpretation of plasma levels in response to antagonist 463 
treatment due to potentially opposing effects of 11β-HSD2 blockage between tissues. The 464 
complexity of 11β-HSD action has been previously highlighted by studies in 11β-HSD1 465 
knockout mice, which display compensatory adrenal hyperplasia and increased basal levels of 466 
corticosterone, despite the presumed absence of hepatic corticosterone reactivation from 467 
cortisone (Kotelevtsev et al., 1997). Additionally, in this study it was found that the adrenal 468 
glands continued to effectively secrete corticosterone in 11β-HSD1 knockout animals, which 469 
also displayed increased adrenal sensitivity to ACTH stimulation. While the results of our 470 
present study support clear involvement of peripheral tissue 11β-HSD2 in regulation of 471 
circulating corticosterone levels, the study design prevents the disentanglement of the 472 
contribution of 11β-HSD2 from specific tissues. Development of novel targeted approaches to 473 
separate these tissue specific effects will be critical to advancing our understanding of peripheral 474 
corticosterone metabolism. 475 
 11β-HSD1 and 11β-HSD2 expression were low in the brain and this is consistent with 476 
previous studies in chickens and zebra finches. However, the contribution of 11β-HSD activity in 477 
modulating neural negative feedback to the hypothalamus remains unclear. In rats, 11β-HSD2 478 
has been co-localized with GR and MR in the brain, strongly suggests important local regulatory 479 
action by these enzymes (Whorwood et al., 1992). Similar data is lacking in free living species; 480 
such co-localization data is needed to clarify the potential of 11β-HSD enzymes to modulate 481 
corticosterone activity.  Existing data from avian studies of neural distribution of MR and GR 482 
receptors may provide limited insight, but must be interpreted with caution. Both MR and GR 483 
appear to be generally widely distributed within the avian brain (Senft et al., 2016; Rensel et al., 484 
2018). In white-crowned sparrows, GR was strongly expressed in hypothalamus but concentrated 485 
primarily in the PVN and pre-optic areas (POA) (Krause et al., 2015). However, caution must be 486 
taken in extrapolating as these data are drawn from observation of breeding as opposed to 487 
wintering (present study) white-crowned sparrows and brain-wide localization of 11β-HSD1 and 488 
11β-HSD2 remains lacking in this species. Regional co-localization by RT-PCR of both MR and 489 
GR expression with 11β-HSD2 expression has been found in zebra finches (Rensel et al., 2018). 490 
While this supports an active role for 11β-HSD2 in modulating local corticosterone 491 
 
 
concentrations within the avian brain, the lack of neuroanatomical co-localization precludes 492 
determination of a functional relationship between the two proteins.  493 
The present work adds to a growing body of literature that supports a significant role for 494 
11β-HSD2 regulatory enzyme action in mediating localized tissue exposure and basal 495 
glucocorticoid levels, in addition to modulation in response to stressors. While complete 496 
elucidation of role of 11β-HSD2 enzymatic actions in HPA axis modulation remains 497 
unexplained, it is clear that 11β-HSD2 is vital in the regulation of tissue specific exposure to 498 
glucocorticoids. Future work addressing tissue and brain region specific functional contributions 499 
of 11β-HSD enzymes are required to fully explain the roles played in HPA axis regulation. 500 
 501 
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Table 1. qPCR Primers utilized in this study. 663 
    Target Accession No. Forward Primer   Reverse Primer 
11β-HSD1 XM_005492865.1 5’GCTCATCCTCAACCACATCG 
 
5’CCATCTAGGGCGAACTTGGT 
11β-HSD2 XM_014269709.1 5’ATATCCAGGCCCACACCAAC 
 
5’CACGTTGTCCCTGTTTTGTAGT 
YHWAZ NM_001031343.1 5'GTGGAGCAATCACAACAGGC 
 
5'GCGTGCGTCTTTGTATGACTC 
NDUFA1 NM_001302115.1 5'ATGTGGTACGAGATCCTGCC 
 
5'TTCTCCAGACCCTTGGACAC 
         
  664 
 665 
 666 
Fig. 1. Relative expression of 11βHSD1 mRNA as measured by qPCR for female (black) and 667 
male (grey) non-breeding Gambel’s white-crowned sparrows across multiple tissues. Letters that 668 
are different from one another indicate significant differences (p < 0.05) between tissues as 669 
determined by post-hoc testing (Tukey’s HSD). N = 9 per sex per tissue, except for male 670 
gastrocnemius muscle n= 8, gonad n= 6, and anterior pituitary n= 6. Expression was standardized 671 
against the geometric mean of YWHAZ and NDUFA reference gene expression. Values are 672 
expressed as means + SEM. 673 
 674 
 675 
Fig. 2. Relative expression of putative 11βHSD2 mRNA as measured by qPCR for female 676 
(black) and male (grey)  non-breeding Gambel’s white-crowned sparrows across multiple tissues. 677 
Letters that are different from one another indicate significant differences (p < 0.05) differences 678 
between tissues as determined by post-hoc testing. N = 9 per sex per tissue, except for male 679 
gastrocnemius muscle n= 8, gonad n= 7, and anterior pituitary n= 6. Expression was standardized 680 
against YWHAZ and NDUFA reference gene expression. Values are expressed as means + 681 
SEM. 682 
 683 
  684 
Fig. 3. The effects pharmacological specific inhibition of CORT synthesis using MET and 685 
inhibition of 11β-HSD2 clearance of CORT using DETC on plasma concentrations of 686 
 
 
corticosterone. Effects of a single bolus peripheral injections of MET (combined 15 & 30 mg/kg; 687 
n = 21) and DETC (combined 200 & 400 mg/kg; n = 21) versus controls (100 µL of Lactated 688 
Ringers solution; n=12) on plasma corticosterone concentrations over a A) one hour handling 689 
restraint sampling period and B) integrated hormonal response using integrated area under the 690 
curve (AUC). Dose had no effect on corticosterone so samples were pooled. Effects of central 691 
infusion of Lactated Ringers solution (n = 30), MET (90 nmol; n = 11) and DETC (900 nmol; n 692 
= 13) into the third ventricle on corticosterone concentrations over a C) one hour sampling 693 
period and D) Integrated area under the curve over the same period.  An initial blood sample was 694 
taken and then birds were immediately injected with the drug. Data analyses by linear mixed 695 
effects model, with Tukey’s HSD post-hoc testing. Letters indicate significant differences 696 
(P<0.05) between treatments at given time point. Values represent means ± SEM.  697 
 698 
 699 
Model Fixed Effects Random Effects 
Peripheral Time Series Time X Drug Bird ID, Assay 
Peripheral Area Under 
the Curve 
Drug Assay 
Central Tme Series Time X Drug Bird ID, Assay 
Central Area Under the 
Curve 
Drug Bird ID, Assay 
  700 
Table 2. Summary of final mixed effects models used in statistical analyses. 701 
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